New York - Because of defective artificial hip joints, the US pharmaceutical company Johnson & Johnson is paying affected patients in the US $ 2.5 billion (1.8 billion euros).
The manufacturer DePuy, subsidiary of Johnson & Johnson, said settlement with patient advocates was brought to justice yesterday. It is estimated that 8,000 patients will have to be operated on again after hip replacement to have their hip prosthesis replaced.
In August 2010, DePuy started recall campaign for two models of hip prostheses, of which the company claims to have sold 93,000 units worldwide by then would have. As result, thousands of patients filed lawsuits in the United States.